DUBLIN--(BUSINESS WIRE)--The "Global Cancer Immunotherapy Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Cancer Immunotherapy Market was valued at $45 billion in 2016, and is estimated to reach $119 billion by 2023, growing at a CAGR of 15% during the forecast period.
Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.
The key factors driving the growth of cancer immunotherapy market are raising incidence and prevalence of cancer, technologically advanced treatment therapies, Growing R&D activities to treat cancer, and specificity & effectiveness of cancer immunotherapy for the treatment of wide range of cancers such as lung cancer, breast cancer, skin cancer, and others. Also, growing healthcare expenditure and better healthcare insurance coverage would further add to the market growth during the analysis period.
Nevertheless, lack of professional healthcare experts and limited awareness about possible solutions among the population are the factors that limit the growth.
- Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and other Technology.
- Based on End User is segmented into Polymeric Coatings and Organic Coatings.
- The Application covered under the report includes Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and other Cancer.
The market research report covers the analysis of key stake holders of the Global Cancer Immunotherapy Market.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Global Cancer Immunotherapy Market
Chapter 4. Global Cancer Immunotherapy Market by End User
Chapter 5. Global Cancer Immunotherapy Market by Application
Chapter 6. Global Cancer Immunotherapy Market by Region
Chapter 7. Company Profiles
- Novartis AG
- Astrazeneca Plc.
- Amgen Inc.
- Immunomedics, Inc.
- Bayer AG
- Pfizer Inc.
- Bristol-Myers Squibb
- Merck Sharp & Dohme Corp.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/n4wx48/global_cancer?w=4